InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Schimmelpennink Evert B.. Officer active across 1 company, notably LENZ Therapeutics, Inc.. In total, 2 disclosures have been recorded. Activity tracked since 22 July 2024. The latest transaction was filed on 7 March 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations